Ulcer News and Research

RSS

Twenty-five million Americans suffer from ulcers. An ulcer is a sore or hole in the lining of the stomach or duodenum (the first part of the small intestine). People of any age can get an ulcer and women are affected just as often as men.

Helicobacter pylori (H. pylori) is a bacterium that lives on the lining of the stomach. Although we used to think that spicy food, acid, and stress were the major causes of ulcers, we now know that nine out of ten ulcers are caused by H. pylori. Medicines that reduce stomach acid may make you feel better, but your ulcer may come back. Here's the good news: Since most ulcers are caused by this bacterial infection, they can be cured with the right antibiotics.

Researchers discover promising new compound against Buruli ulcer

Buruli ulcer - one of the most neglected among the NTDs - is a debilitating and stigmatizing disease. Affecting mainly children in West and Central Africa, the chronic disease results in devastating skin lesions and can lead to permanent disfigurement and long-term disabilities.

18 Dec 2018

New app accurately measures and charts progression of skin wounds

Monitoring a wound is critical, especially in diabetic patients, whose lack of sensation due to nerve damage can lead to infection of a lesion and, ultimately, amputation.

18 Dec 2018

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

A Vanderbilt University Medical Centerstudy published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor in combination with an oral anticoagulant.

4 Dec 2018

New shoe insole technology could help diabetic ulcers heal better while walking

Diabetes can lead to ulcers that patients don't even feel or notice until the sight of blood. And because ulcers can't heal on their own, 14 to 24 percent of diabetics in the U.S. who experience them end up losing their toes, foot or leg.

16 Nov 2018

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular outcomes trial DECLARE -TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company's Cardiovascular, Renal & Metabolism therapy area at the American Heart Association Scientific Sessions, November 10-12, 2018, in Chicago, Illinois, USA.

1 Nov 2018

Healogics to take part in campaign highlighting link between diabetes and chronic wounds

Healogics, the nation's wound healing expert, is proud to participate in a national diabetes awareness campaign October 29 through November 2. This campaign will highlight the important connection between diabetes and chronic wounds and their recurrence.

30 Oct 2018

NHS comes up with a list of 20 most painful conditions

The NHS has listed 20 most painful conditions that are such excruciatingly painful that they can lead to severe debilitation that prevents a person from performing their daily activity.

29 Oct 2018

Patients once thought incurable can benefit from high-dose radiation therapy

In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase how long oligometastatic patients live and doubles how long they live without cancer.

17 Oct 2018

World Stomach Day: International initiative to raise awareness and support for a vital organ

Tuesday, 2 October 2018 marks the first ever World Stomach Day, an international initiative to raise awareness and support for one of our most vital organs.

3 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

Avoidable sepsis infections send thousands of seniors to gruesome deaths

Shana Dorsey first caught sight of the purplish wound on her father's lower back as he lay in a suburban Chicago hospital bed a few weeks before his death.

6 Sep 2018

Researchers program open wound cells to turn into healthy skin

Researchers at the Salk Institute have found a way to convert the cells in open wounds into new skin cells, potentially eliminating the need for plastic surgery in the treatment of large wounds.

6 Sep 2018

Presence of new or worsened bedsores associated with lower quality outcomes for rehab patients

A new study from the University at Buffalo has shown that the presence of new or worsened bedsores is an effective indicator of the quality of care for rehab patients.

31 Aug 2018

Patients with chronic pain feel caught in an opioid-prescribing debate

It started with a rolled ankle during a routine Army training exercise. Shannon Hubbard never imagined it was the prologue to one of the most debilitating pain conditions known to exist, called complex regional pain syndrome.

1 Aug 2018

Frailty associated with poor survival rates in young heart patients

Traditionally, frailty is thought to be a syndrome of the elderly - one which comes as a natural and inevitable side-effect of aging, gradually transforming strong, healthy bodies into weaker, more delicate frames over time.

20 Jul 2018

Researchers develop ingestible sensor to non-invasively monitor indicators of disease

NIBIB-funded researchers at the Massachusetts Institute of Technology have created an ingestible sensor to non-invasively monitor indicators of disease in the stomach and intestines.

6 Jul 2018

Expert explains how wounds impose health economic burden on the UK's NHS

It is estimated that annually the NHS treats over two million wounds at a cost of £5.3 billion and with tougher financial constraints being announced every year, there needs to be ongoing research to ensure the lack of finances doesn't affect the quality of wound care available.

3 Jul 2018

Acoustic technology could offer new way to diagnose IBS

Utilizing newly adapted artificial intelligence, researchers have developed an acoustic belt that offers a new way to diagnose irritable bowel syndrome by listening to the noises in a patient's gut, according to research presented at Digestive Disease Week 2018.

5 Jun 2018

Clinical study shows promising results of Nexodyn AcidOxidizing Solution in healing chronic wounds

APR Applied Pharma Research sa, the Swiss independent developer of science driven and patent protected healthcare products, today announces the publication in "Advances in skin & wound care" of the results of a clinical pilot study on the efficacy and tolerability of Nexodyn AcidOxidizing Solution, a sprayable Active Cleanser with ancillary antimicrobial activity developed for acute and chronic wound management.

16 May 2018